Furofushi Research Partners with Yuurea for Data-Driven Health Solutions

Furofushi Research (Headquarters: Shinjuku, Tokyo; CEO: Koji Hayashi) has entered into a business partnership with Yuurea Inc. (Headquarters: Nagoya, Aichi; CEO: Shogo Mizuno), a company specializing in instant urine analysis technology, to provide health management solutions based on bio-data and engage in collaborative research.

Background: From Subjectivity to Data-Driven Design Based on the philosophy of realizing a world where everyone can smile and shine throughout their lives, the institute views health as life's greatest asset and pursues the extension of "healthspan."

Believing that maintaining daily conditions is the driving force behind a vibrant life, the institute uses high-purity "Reduced Coenzyme Q10" from Kaneka Corporation and "Assist NMN" from Kobayashi Perfumery. The institute supports those who wish to maintain vitality and youthfulness from within.

By adding objective data to the subjective "experience" and "sense of security" provided by supplements, health management can evolve. Through this partnership, they will utilize Yuurea's unique instant urine analysis technology to capture "changes in physical conditions" as objective bio-data. By combining their products with this technology, they aim to transition health management from "feeling-based" to "data-driven design."

Specific Initiatives 1. Personalized Recommendations and Collaborative Research using Bio-data By introducing urine testing kits and a dedicated app, they will create an environment that supports optimal intake habits based on individual measurement data. They will also conduct collaborative research on recording conditions before and after supplement intake to refine product design and build scientific evidence. (Analysis data will be anonymized and strictly managed.)

2. Joint Development of Next-Generation Healthcare Solutions Looking ahead, they plan to strengthen their long-term partnership with an eye toward co-developing new testing kits that fuse both companies' technologies. They aim to "democratize health management" and create a society where everyone can proactively optimize their own condition.